Translational molecular imaging and drug development in Parkinson’s disease

Translational molecular imaging and drug development in Parkinson’s disease

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects elderly people and constitutes a major source of disability worldwide. Notably, the neuropathological hallmarks of PD include nigrostriatal loss and the formation of intracellular inclusion bodies co...

Full description

Bibliographic Details
Main Authors: Ahmed Haider, Nehal H. Elghazawy, Alyaa Dawoud, Catherine Gebhard, Thomas Wichmann, Wolfgang Sippl, Marius Hoener, Ernest Arenas, Steven H. Liang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Molecular Neurodegeneration
Subjects:
Translational molecular imaging
Parkinson’s disease
Drug development
Dopamine
α-Synuclein
Mitochondrial dysfunction
Online Access:https://doi.org/10.1186/s13024-023-00600-z

Internet

https://doi.org/10.1186/s13024-023-00600-z

Similar Items